Chris Sarampote, Ph.D.
Chief, Biomarker and Intervention Development for Childhood-Onset Disorders Branch
Division of Translational Research
National Institute of Mental Health (NIMH)
National Institutes of Health
6001 Executive Boulevard, Room 7130, MSC 9637
Bethesda, MD 20892-9617
Phone: (301) 443-1959
Christopher Sarampote, Ph.D., is Chief of the Biomarker and Intervention Development for Childhood-Onset Disorders Branch within the Division of Translational Research at NIMH. He has worked at NIMH for over 15 years, first serving as a Scientific Review Officer then as a Program Officer focused on child traumatic stress, research training and career development, and pediatric mental health intervention. Dr. Sarampote holds a bachelor’s degree in Psychology from St. Mary’s College of Maryland and a master’s degree and PhD in Clinical Psychology from George Mason University. He completed his predoctoral internship at SUNY Upstate Medical University and postdoctoral fellowships at the Kennedy Krieger Institute and George Washington University School of Medicine and Health Sciences. He continued his work at Children’s National Medical Center where, in addition to providing direct care to children and families, he studied the pharmacogenetics of stimulant treatment for ADHD and collaborated with researchers at the National Human Genome Research Institute on the first large scale GWAS study of ADHD.